Search / Trial NCT06223802

Biodex Training in Hemodialysis Females With Osteopenia

Launched by AHRAM CANADIAN UNIVERSITY · Jan 16, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Description

58 women with osteopenia problem and dialysis will be divided to trained women group with a number of 29 women receiving 3-time biodex training per week, every time will be 10 minutes for 12 weeks or nontrained women group that will act as a control group (n = 29 women)

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * osteopneia women
  • * hemodialysis women
  • Exclusion Criteria:
  • * pregnancy
  • * autoimmune disorders
  • * lower limb orthopedic problems
  • * psychological manifestaion

About Ahram Canadian University

Ahram Canadian University is a distinguished educational institution committed to advancing research and innovation in the field of healthcare. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct rigorous research studies that contribute to the understanding of medical treatments and interventions. By fostering collaboration among researchers, healthcare professionals, and industry partners, Ahram Canadian University aims to enhance patient outcomes and drive the development of evidence-based practices in medicine. Through its commitment to ethical standards and scientific integrity, the university plays a pivotal role in shaping the future of healthcare research.

Locations

Giza, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0